BCG
Binah Capital Group, Inc.
There isn't enough reported data to score BCG yet.
MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
BCG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
BCG's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BCG.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
BCG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 5.3x | $1.10 | — |
| Cheap | 8x | $1.67 | +52% |
| Fair | 15x | $3.25 | +196% |
| Expensive | 76x | $16.04 | +1358% |
Historical ranges are pointers, not guarantees.
BCG has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
BCG Forward outlook
There aren't enough analyst estimates for BCG to show an outlook.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
BCG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.21 | +600% |
| Q2 2026 | $0.16 | +$0.28 |
| Q1 2026 | $0.12 | +$0.24 |
| Q4 2025 | $0.09 | +$0.41 |
| Q3 2025 | $0.03 | +$0.33 |
| Q2 2025 | -$0.12 | +$0.09 |
| Q1 2025 | -$0.12 | +$0.05 |
| Q4 2024 | -$0.32 | -900% |
BCG's earnings per share have fallen from their peak: $0.21 over the past year, against $0.36 in mid-2022.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over BCG on earnings, with more consistent year-over-year improvement.
BCG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.6M | +9.4% |
| Q2 2026 | $46.5M | +12% |
| Q1 2026 | $48.7M | -0.5% |
| Q4 2025 | $50.5M | +13% |
| Q3 2025 | $46.2M | +9.5% |
| Q2 2025 | $41.5M | +2.1% |
| Q1 2025 | $48.9M | +18% |
| Q4 2024 | $44.6M | +13% |
BCG's revenue is growing: $51M last quarter, up 9.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8% | +3.8 points |
| Q2 2026 | 0.9% | +2.3 points |
| Q1 2026 | 5.5% | +2.5 points |
| Q4 2025 | -0.5% | +0.8 points |
| Q3 2025 | 4.2% | +5.7 points |
| Q2 2025 | -1.4% | -0.1 points |
| Q1 2025 | 3% | +6.5 points |
| Q4 2024 | -1.3% | -0.8 points |
BCG's operating margin was 8% last quarter, up 3.8 points from the same quarter a year ago, near the top of its range since 2021.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over BCG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over BCG on profitability, with a higher operating margin.
BCG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1M | +246% |
| Q2 2026 | $1.1M | +1651% |
| Q1 2026 | $527K | -50% |
| Q4 2025 | $3.1M | +79% |
| Q3 2025 | $884K | +$1.2M |
| Q2 2025 | $63K | -94% |
| Q1 2025 | $1M | +$4.2M |
| Q4 2024 | $1.7M | -36% |
BCG has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
BCG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +2% | +340K shares |
| 3 years | +11% | +1.8M shares |
| 5 years | +19% | +2.7M shares |
BCG has 17M diluted shares, up 2% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | $691 |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $102.9M |
| Q1 2022 | — |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over BCG on shareholder dilution, with a more favorable share count trend.
BCG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -1.6x | Net Cash |
| Q3 2025 | -3.4x | Net Cash |
| Q1 2025 | -61.3x | Net Cash |
| Q2 2024 | -3.0x | Net Cash |
| Q1 2024 | -0.3x | Net Cash |
BCG has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
BCG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 20.7 | Neutral |
BCG's weekly RSI is 37 (neutral) and its Stochastic is 21 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
BCG PE vs Financial Services Sector
| Metric | BCG | Sector median | Relative |
|---|---|---|---|
| PE | 5.3x | 13x | 59% below |
| PE % | 0 | 31 | 31 pts below |
BCG has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
BCG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.07 | 2.8% above |
| 20 week MA | $1.27 | 13% below |
| 50 week MA | $1.76 | 37% below |
| 100 week MA | $1.94 | 43% below |
MS has stronger trend alignment. BCG is above 1 of 4 weekly averages versus MS above 3 of 5.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
BCG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $13.0 | $2.90 | -78% |
| 2025 | $2.90 | $2.39 | -18% |
| 2026 YTD | $2.39 | $1.10 | -54% |
BCG has finished every year since 2024 lower, and it's down 54% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over BCG on returns for 2026, with the stronger performance.